SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63365 356 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
62468What is IGN? Thanks!TripleE3-3/1/2024
62467BIVI moving this am: trading perspectives: note that SAVA competitor BIVI is up scorman1-3/1/2024
62466Thanks, that makes more sense...erickerickson-2/29/2024
62465They are projected to be cash flow positive in Q3 of this year. So $150 millionIMMUzombie12/29/2024
62464AUPH and share repurchase: AURINIA RECEIVES EXEMPTIVE RELIEF FROM CANADIAN SECUerickerickson-2/29/2024
62463drtom CTMX price is moving up on much higher volume the last couple days, have bgscolt-2/28/2024
62462It reads as 500 of the 555 who have completed either ReThink or ReFocus have conDavidoff32/28/2024
62461SAVA 8K Here's the press release: 8K press release About the only thing nerickerickson12/28/2024
62460I am similarly circumspect about this being a short squeeze; just raising the quOlecranon-2/27/2024
62459ALT and short squeeze.. I've pretty much given up on the notion of short sqerickerickson-2/27/2024
62458ALT has shot up over 2 days on no public IGN. Are we looking at a short squeezeOlecranon-2/27/2024
62457Some days you're the pigeon, and some days you're the statue... Over therickerickson12/26/2024
62456ALT: I just love reporting. Seeking Alpha articles: Feb 13: "Altimmune skerickerickson-2/24/2024
62455I took a quick look at PRLD. They have three P1 trials, two are recruiting and oerickerickson-2/24/2024
62454Oct 2nd, Cassava announced completion of enrollment in 12 mo phase 3 trial. Lastscorman1-2/23/2024
62453AUPH passing out shares like candy... Just got a bunch of notifications of tranerickerickson-2/22/2024
62452I am not in a hurry to invest my CBAY winnings. The market in general is tradinOlecranon22/20/2024
62451One of the hopes I have with Simufilam is not just some level of efficacy -- in allatwwk32/20/2024
62450new Alz article from London Times " ‘Revolutionary’ Alzheimer’s drugs couldscorman112/20/2024
62449One of my issues with biopharma investing, has been the relative failure of compallatwwk-2/20/2024
62448I am interested in Spyre as well. Before jumping in there I am curious about theIMMUzombie-2/18/2024
62447SYRE and GLUE Ghetto: Yeah, the numbers seem to be screwy, it hurts my head toerickerickson-2/17/2024
62446Wow 45%. I'm seeing 36M shares outstanding on most sites. That is strange, sghettogoulash-2/17/2024
62445I do not see that AVORO owns any GLUE. I must be missing something but it's galt-2/17/2024
62444"I am currently looking at some new ideas to invest my CBAY earnings" erickerickson12/17/2024
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News